Skip to main content
Clinical Trials/NCT04729231
NCT04729231
Withdrawn
Not Applicable

A Randomized Controlled Trial Comparing the Functional and Aesthetic Outcomes of Lobed Transposition Flaps vs. Nasalis Sling Flaps in Nasal Tip Reconstruction

Northwestern University1 site in 1 country32 target enrollmentJanuary 2025
ConditionsSurgical Wound

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Surgical Wound
Sponsor
Northwestern University
Enrollment
32
Locations
1
Primary Endpoint
Visual Analog Scale (VAS)
Status
Withdrawn
Last Updated
12 months ago

Overview

Brief Summary

The purpose of this study is to determine whether there is a significant difference in aesthetic and functional outcomes between nasalis sling flaps and lobed flaps of nasal tip wounds requiring reconstruction.

This is a randomized clinical trial. Approximately 32 participants who are undergoing nasal tip wound reconstruction surgery will be invited to participate and randomized to receive either the nasalis sling repair or the lobed flap repair. Patients will be asked to complete a few questionnaires including a VAS scale, the Surgical Outcomes scale, the NOSE instrument, and the Nasal Appearance and Function Evaluation Questionnaire (NAFEQ).

This study was a pilot study designed to determine the feasibility of these procedures.

Registry
clinicaltrials.gov
Start Date
January 2025
End Date
May 1, 2025
Last Updated
12 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Murad Alam

Professor of Dermatology

Northwestern University

Eligibility Criteria

Inclusion Criteria

  • All patients \>18 years
  • Defect located on the nasal tip, infratip, or supratip of the nose
  • Longest length of the wound should be no greater than 15mm
  • Participants must have the ability to understand and the willingness to sign a written informed consent prior to registration on study

Exclusion Criteria

  • Active infection
  • Investigator judgement that patient is not suitable for randomization (preexisting scars or architecture that would make one repair option less likely to be successful)
  • Current cigarette smoking
  • Patients that have a disease or are taking medication that would severely impair wound healing in the opinion of the investigator

Outcomes

Primary Outcomes

Visual Analog Scale (VAS)

Time Frame: 6-16 weeks after the procedure

This visual analog scale (VAS) measures outcomes of functionality and appearance with values ranging on a continuum from 0 to 10, and higher scores representing a better outcome.

Nasal Obstruction Symptom Evaluation (NOSE) Instrument

Time Frame: Baseline to 6-16 weeks

The Nasal Obstruction Symptom Evaluation (NOSE) Instrument is a questionnaire of nose functionality. This is a checklist of of problems related to the nose/nasal area with possible answers ranging from "not a problem" to a "severe problem".

Surgical Outcome Scale

Time Frame: 6-16 weeks after the procedure

The Surgical Outcome Scale is a likert agreement scale on surgical outcomes with values ranging from 1 (agree) to 5 (disagree), and lower scores representing a better outcome.

Nasal Appearance and Function Evaluation Questionnaire (NAFEQ) Scale

Time Frame: Baseline to 6-16 weeks

Nasal Appearance and Function Evaluation Questionnaire (NAFEQ) Scale is a likert scale on nasal appearance and function evaluations with values ranging from 1 (always; very poor; very dissatisfied) to 5 (never; excellent; very satisfied), and higher scores representing a better outcome.

Study Sites (1)

Loading locations...

Similar Trials